Table 4

Adjusted OR and HR for the association between bronchiectasis and coronary heart disease (CHD) or stroke from sensitivity analyses

Sensitivity analysis performedOR for CHD (95% CI)OR for stroke (95% CI)HR for CHD (95% CI)HR for stroke (95% CI)
Excluding individuals with coexisting diagnosis of COPD (n=7099)*1.19 (1.09 to 1.29)1.91 (1.81 to 2.02)1.36 (1.15 to 1.60)1.77 (1.55 to 2.02)
Only including individuals without comorbidities associated with the aetiology of bronchiectasis (n=4027)*1.21 (1.08 to 1.34)1.93 (1.80 to 2.07)1.28 (1.08 to 1.48)1.84 (1.55 to 2.17)
Only including current smokers (n=1 401 175)*1.29(1.13 to 1.47)1.79 (1.66 to 1.95)1.41 (1.10 to 1.79)1.65 (1.37 to 1.99)
Only including never-smokers (n=1 644 170)*1.36 (1.23 to 1.50)1.98 (1.85 to 2.13)1.47 (1.19 to 1.80)1.80 (1.51 to 2.14)
Excluding individuals with missing smoking information (n=3 698 015)*1.35 (1.27 to 1.44)1.91 (1.84 to 2.00)1.44 (1.27 to 1.63)1.71 (1.54 to 1.90)
Competing risk adjustmentn/an/a1.39 (1.22 to 1.59)1.76 (1.54 to 2.01)
  • *Adjusted for age, sex, smoking, diabetes mellitus, hypertension, hyperlipidaemia and family history of cardiovascular disease.